Literature DB >> 24334921

Evaluation of weight loss and adipocytokine levels after two hypocaloric diets with different macronutrient distribution in obese subjects with the rs6923761 gene variant of glucagon-like peptide 1 receptor.

Daniel Antonio de Luis1, Rocío Aller, Olatz Izaola, Beatriz de la Fuente, David Primo, Rosa Conde, Manuel González Sagrado.   

Abstract

BACKGROUND: The role of glucagon-like peptide-1 receptor (GLP-1R) variants on body weight response after dietary intervention has not been evaluated so far.
OBJECTIVE: Our aim was to evaluate weight loss and adipocytokine levels after two hypocaloric diets with different macronutrient distribution in obese subjects with rs6923761.
DESIGN: A sample of 280 obese subjects was randomized to two hypocaloric diets.
RESULTS: 124 patients (44.3%) had the genotype GG (wild-type) and 156 (55.7%) had another genotype (mutant), i.e. GA (n = 132, 47.1%) or AA (n = 24, 8.6%). With the type I diet (low in carbohydrates) in the wild-type and mutant groups, BMI, weight, fat mass, waist circumference, insulin levels, insulin resistance and triglycerides decreased. Anthropometric parameters were higher in non-A-allele carriers than A-allele carriers. With the type II diet (low in fats) in all genotypes, BMI, weight, fat mass, waist circumference, insulin levels, total cholesterol and LDL cholesterol decreased.
CONCLUSION: Our data showed better anthropometric parameters in obese subjects with the mutant allele (A) of the rs6923761 GLP-1R polymorphism. A lack of association of this polymorphism with weight loss or biochemical parameters after two different hypocaloric diets was observed.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24334921     DOI: 10.1159/000356710

Source DB:  PubMed          Journal:  Ann Nutr Metab        ISSN: 0250-6807            Impact factor:   3.374


  5 in total

1.  Effects of a high-protein/low-carbohydrate versus a standard hypocaloric diet on adipocytokine levels and cardiovascular risk factors during 9 months, role of rs6923761 gene variant of glucagon-like peptide 1 receptor.

Authors:  D A de Luis; R Aller; O Izaola; E Romero
Journal:  J Endocrinol Invest       Date:  2015-05-27       Impact factor: 4.256

2.  Blood Glucagon Levels Predict the Hemoglobin A1c Response to Saxagliptin in Patients with Type 2 Diabetes Inadequately Controlled with Metformin.

Authors:  Hao Liu; Yun Hu; Feng-Fei Li; Bing-Li Liu; Xiao-Fei Su; Jian-Hua Ma
Journal:  Diabetes Ther       Date:  2016-10-12       Impact factor: 2.945

Review 3.  Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical Perspective.

Authors:  Joanna Michałowska; Ewa Miller-Kasprzak; Paweł Bogdański
Journal:  Nutrients       Date:  2021-01-25       Impact factor: 5.717

Review 4.  Glucagon-like Peptide-1 Receptor Agonists in the Management of Type 2 Diabetes Mellitus and Obesity: The Impact of Pharmacological Properties and Genetic Factors.

Authors:  Jasna Klen; Vita Dolžan
Journal:  Int J Mol Sci       Date:  2022-03-22       Impact factor: 5.923

5.  Genetic Variability of Incretin Receptors and Alcohol Dependence: A Pilot Study.

Authors:  Evangelia Eirini Tsermpini; Katja Goričar; Blanka Kores Plesničar; Anja Plemenitaš Ilješ; Vita Dolžan
Journal:  Front Mol Neurosci       Date:  2022-06-09       Impact factor: 6.261

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.